Major Pharma Sees Tremendous Rise in Short Interest
The February 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 107
Why Tandem Diabetes Shares Are Soaring
Tandem Diabetes shares soared after it reported better-than-expected quarterly results and announced management changes.
Meet Zynerba’s Newest Patent
Zynerba Pharmaceuticals shares jumped on Tuesday after the company announced that it has received a key patent from the U.S. Patent and Trademark Office.
M&A Verdict: Danaher Gets Better Side of the Deal Than GE in Life Sciences Unit Sale
Investors and speculators just love a good merger and acquisition story. The story of General Electric selling its Life Sciences biotechnology instrument division to Danaher is one of those fairy tale mergers.
FDA Warns Against Thermography for Breast Cancer Screening
The FDA has warned a California company against marketing its thermography device as a stand-alone test for breast cancer and other conditions. The device has only been approved for use only when used with…
Which Gene Therapy Companies May Be Most Valuable After Spark Therapeutics Buyout
Spark Therapeutics shares more than doubled in Tuesday’s session as the result of its pending acquisition. However, the root of the buyout was its gene therapy, which could drive more acquisitions in the future,…
Is Roche Spending Too Much for Spark Therapeutics?
Spark Therapeutics shares more than doubled to start out the week after the company announced that it would be acquired by Swiss health care giant Roche, which is looking to add to its portfolio.
What Danaher Gets by Paying $21.4 Billion for GE Biopharma Business
Medical device maker Danaher has agreed to acquire GE's biopharma business for $21.4 billion in cash. The transaction is expected to be completed by the end of this year.
What Ipsen Wants From Clementia Pharmaceuticals
Clementia Pharmaceuticals has entered into an agreement to be acquired by French pharmaceutical company Ipsen.
Why This New Collaboration Is Incredible for Voyager Therapeutics
Voyager Therapeutics shares made an incredible gain on Friday after the firm announced a collaboration with pharma giant AbbVie.
Johnson & Johnson and Other Health Care Stocks With Recent Death Crosses
Here are five top health care stocks that recently saw their 50-day moving average cross below the 200-day average, a death cross.
Is Merck Overpaying for Immune Design?
Immune Design shares absolutely exploded on Thursday after Merck announced that it would be acquiring the firm at what some might call a ridiculous premium
Who’s to Blame for the US Opioid Epidemic
For more than half a decade, the United States has seen an incredible rise of an opioid epidemic within its borders. According to a recent study, drug makers and federal regulators are the ones…
How Intercept Pharma Shatters Expectations With Its Liver Fibrosis Treatment
Intercept Pharmaceuticals shares jumped on Tuesday after the firm announced results for its Phase 3 Regenerate study of obeticholic acid in patients with liver fibrosis due to nonalcoholic steatohepatitis.
Trump Is Obese, Like 93 Million Other Americans
President Donald Trump had his annual physical. He weighs 243 pounds and stands six feet and three inches tall. That gives him a body mass index of 30.4, which is considered “obese.” About 40%…